White Matter Hyperintensity

1

Review clinical trials related to White Matter Hyperintensity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases

Cerebral small vessel disease (cSVD) is a common accompaniment of aging. Recent small subcortical (or lacunar) infarcts (i.e. symptomatic cSVD) and white matter hyperintensities are typical cSVD lesions on neuroimaging. cSVD causes about a quarter of ischaemic strokes and related with cognitive dysfunction. However, few studies are available so far to especially explore the treatment of cSVD. Endothelial dysfunction plays an important part in cSVD. Cilostazol and isosorbide mononitrate have endothelial protective function. We designed this prospective cohort study in China, aiming to evaluate the effect of different antiplatelet agents (e.g. Cilostazol) on cSVD and retina in patients with cSVD (recent small subcortical infarcts or WMH, respectively).

Participants needed: 300
Trial details
Age: 30-79Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: Mar 28, 2025Locations: 1Duration: 6 Months
Eligibility criteria

Age ≥ 30 years and ≤ 79 years. [+4]

Intracranial aneurysms that need surgical treatment. Other significant active ne... [+10]